These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2575137

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The role of the SIV model in AIDS vaccine research.
    Friedrich TC, Watkins DI.
    IAVI Rep; 2005; 9(2):1, 6-8. PubMed ID: 16156073
    [No Abstract] [Full Text] [Related]

  • 25. Neutralizing antibody and clinical status of human immunodeficiency virus (HIV)-infected individuals.
    Alesi DR, Ajello F, Lupo G, Vitale F, Portera M, Spadaro F, Romano N.
    J Med Virol; 1989 Jan; 27(1):7-12. PubMed ID: 2784162
    [Abstract] [Full Text] [Related]

  • 26. A macaque adherent cell line that expresses human CD4 is susceptible to SIV: utility for assessing neutralizing antibody.
    Goldstein S, Hague B, Montefiori D, Hirsch VM.
    J Virol Methods; 1995 May; 53(1):139-48. PubMed ID: 7635923
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Quantitative determination of the infective activity of the human immunodeficiency virus by plaque formation using monolayer cultures].
    Nosik MN, Stepanova LG, Matsevich GR.
    Vopr Virusol; 1995 May; 40(5):202-5. PubMed ID: 8659172
    [Abstract] [Full Text] [Related]

  • 34. A sensitive assay for detection and measurement of neutralising antibody to human immunodeficiency virus.
    Osborne R, Mason H, Browning M, Mitchell R, Jarrett W.
    J Virol Methods; 1992 Sep; 39(1-2):15-26. PubMed ID: 1430060
    [Abstract] [Full Text] [Related]

  • 35. Enhancement of SIV infection with soluble receptor molecules.
    Allan JS, Strauss J, Buck DW.
    Science; 1990 Mar 02; 247(4946):1084-8. PubMed ID: 2309120
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Isolation and partial characterization of an HIV-related virus occurring naturally in chimpanzees in Gabon.
    Peeters M, Honoré C, Huet T, Bedjabaga L, Ossari S, Bussi P, Cooper RW, Delaporte E.
    AIDS; 1989 Oct 02; 3(10):625-30. PubMed ID: 2512955
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.